AR032240A1 - Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c - Google Patents

Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c

Info

Publication number: AR032240A1
Authority: AR; Argentina
Prior art keywords: protein; proteins; therapeutic vaccine; compilition; profilactic
Prior art date: 2001-01-11

Application number

ARP020100104A

Other languages

English (en)

Spanish (es)

Original Assignee

Innogenetics Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-11

Filing date

2002-01-14

Publication date

2003-10-29

2002-01-14 Application filed by Innogenetics Nv filed Critical Innogenetics Nv

2003-10-29 Publication of AR032240A1 publication Critical patent/AR032240A1/es

Links

102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
229940021747 therapeutic vaccine Drugs 0.000 title abstract 2
241000711557 Hepacivirus Species 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
101710125507 Integrase/recombinase Proteins 0.000 abstract 2
101710185720 Putative ethidium bromide resistance protein Proteins 0.000 abstract 2
238000010494 dissociation reaction Methods 0.000 abstract 2
230000005593 dissociations Effects 0.000 abstract 2
101710091045 Envelope protein Proteins 0.000 abstract 1
101710188315 Protein X Proteins 0.000 abstract 1
102100021696 Syncytin-1 Human genes 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000002934 lysing effect Effects 0.000 abstract 1
238000012544 monitoring process Methods 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
238000004393 prognosis Methods 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
229940021993 prophylactic vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ARP020100104A 2001-01-11 2002-01-14 Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c AR032240A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US26066901P	2001-01-11	2001-01-11
US31576801P	2001-08-30	2001-08-30

Publications (1)

Publication Number	Publication Date
AR032240A1 true AR032240A1 (es)	2003-10-29

Family

ID=26948130

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP020100104A AR032240A1 (es)	2001-01-11	2002-01-14	Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c

Country Status (16)

Country	Link
EP (1)	EP1463753A2 (pl)
KR (1)	KR20020089371A (pl)
CN (1)	CN1547588A (pl)
AR (1)	AR032240A1 (pl)
AU (1)	AU2002238502B2 (pl)
BR (1)	BR0203518A (pl)
CA (1)	CA2400643A1 (pl)
CZ (1)	CZ20032164A3 (pl)
HU (1)	HUP0302416A2 (pl)
IL (1)	IL151033A0 (pl)
MX (1)	MXPA02008886A (pl)
NO (1)	NO20024325L (pl)
PL (1)	PL363175A1 (pl)
RU (1)	RU2313363C2 (pl)
TR (1)	TR200202169T1 (pl)
WO (1)	WO2002055548A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4261195B2 (ja)	2001-04-24	2009-04-30	イノジェネティックス・ナムローゼ・フェンノートシャップ	酵母のコア−グリコシル化されたｈｃｖエンベロープタンパク質の発現
AU2003283365A1 (en) *	2002-11-08	2004-06-07	Innogenetics N.V.	HCV vaccine compositions comprising E1 and NS3 peptides
EP1561470A1 (en) *	2003-06-20	2005-08-10	Innogenetics N.V.	HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent
KR20060087574A (ko) *	2003-09-22	2006-08-02	가부시키가이샤 그린 펩티드	Ｃ형 간염 바이러스 유래 펩티드
CN100365124C (zh) *	2005-10-27	2008-01-30	云南大学	一段丙型肝炎病毒特异性cDNA序列的应用
CN115980352A (zh) *	2022-12-30	2023-04-18	宁波博肽生物技术有限公司	一种hcv抗原包被预处理剂、抗原包被方法及检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996004385A2 (en) *	1994-07-29	1996-02-15	Innogenetics N.V.	Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

2002
- 2002-01-11 PL PL02363175A patent/PL363175A1/pl unknown
- 2002-01-11 EP EP02704649A patent/EP1463753A2/en not_active Withdrawn
- 2002-01-11 TR TR2002/02169T patent/TR200202169T1/xx unknown
- 2002-01-11 IL IL15103302A patent/IL151033A0/xx unknown
- 2002-01-11 CZ CZ20032164A patent/CZ20032164A3/cs unknown
- 2002-01-11 RU RU2002121632/15A patent/RU2313363C2/ru not_active IP Right Cessation
- 2002-01-11 CN CNA028006097A patent/CN1547588A/zh active Pending
- 2002-01-11 BR BR0203518-9A patent/BR0203518A/pt not_active IP Right Cessation
- 2002-01-11 WO PCT/EP2002/000219 patent/WO2002055548A2/en not_active Ceased
- 2002-01-11 HU HU0302416A patent/HUP0302416A2/hu unknown
- 2002-01-11 AU AU2002238502A patent/AU2002238502B2/en not_active Ceased
- 2002-01-11 KR KR1020027011431A patent/KR20020089371A/ko not_active Abandoned
- 2002-01-11 CA CA002400643A patent/CA2400643A1/en not_active Abandoned
- 2002-01-11 MX MXPA02008886A patent/MXPA02008886A/es active IP Right Grant
- 2002-01-14 AR ARP020100104A patent/AR032240A1/es unknown
- 2002-09-10 NO NO20024325A patent/NO20024325L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR200202169T1 (tr)	2004-06-21
PL363175A1 (pl)	2004-11-15
IL151033A0 (en)	2003-04-10
HUP0302416A2 (hu)	2003-10-28
WO2002055548A8 (en)	2002-10-31
AU2002238502B9 (en)	2002-07-24
BR0203518A (pt)	2002-12-17
WO2002055548A3 (en)	2004-08-05
RU2313363C2 (ru)	2007-12-27
MXPA02008886A (es)	2003-04-25
NO20024325L (no)	2002-11-11
WO2002055548A2 (en)	2002-07-18
AU2002238502B2 (en)	2007-09-06
AU2002238502A1 (en)	2002-07-24
RU2002121632A (ru)	2004-03-20
EP1463753A2 (en)	2004-10-06
KR20020089371A (ko)	2002-11-29
CZ20032164A3 (cs)	2003-10-15
CA2400643A1 (en)	2002-07-18
NO20024325D0 (no)	2002-09-10
CN1547588A (zh)	2004-11-17

Legal Events

Date	Code	Title	Description
2010-11-19	FB	Suspension of granting procedure

Publication	Publication Date	Title
Wiktor et al.	1973	Antigenic properties of rabies virus components
ES2174957T3 (es)	2002-11-16	Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
PT1090033E (pt)	2005-05-31	Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
MXPA02011545A (es)	2003-06-06	Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
EA200300318A1 (ru)	2004-02-26	Пептидомиметические ингибиторы протеазы
BR0312474A (pt)	2005-04-26	Partìcula viral adjuvante
DE60039715D1 (de)	2008-09-11	Hcv-impfstoff zusammensetzungen
NO20044897L (no)	2005-02-18	Hepatitt C virus inhibitorer
JP2003528887A5 (pl)	2007-06-28
WO2002086100A3 (en)	2004-02-19	Expression of core-glycosylated hcv envelope proteins in yeast
CL2020000295A1 (es)	2020-12-04	Métodos de terapia génica del factor viii (fviii)
MXPA05005202A (es)	2006-01-27	Vacuna.
MXPA04005891A (es)	2004-09-13	Proteinas envolventes del virus de hepatitis c purificadas para diagnostico y uso terapeutico.
BR0206995A (pt)	2005-08-16	Tratamento do vìrus da hepatite b
SE9903031D0 (sv)	1999-08-27	Peptide mixture and vaccine against a chronic viral infection
LU et al.	2005	Preparation and development of equine hyperimmune globulin F (ab′) 2 against severe acute respiratory syndrome coronavirus 1
EP1797112A4 (en)	2009-04-01	INHIBITORS OF HEPATITIS C VIRUS
WO2004041853A3 (en)	2004-07-15	Hcv vaccine compositions comprising e1 and ns3 peptides
TR200202169T1 (tr)	2004-06-21	Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
AR041515A1 (es)	2005-05-18	Vacuna a dna contra el virus de papiloma humano
ATE430167T1 (de)	2009-05-15	Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
RU2004104357A (ru)	2005-07-10	Вакцинный состав, потенцированный комбинацией днк и антигена
ECSP003414A (es)	2001-02-21	Peptidos macrociclicos activos frente al virus de la hepatitis c
JP2004525885A5 (pl)	2005-12-22